A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
0
Participant gender:
All
Summary
Study GIPF-001 is phase 3 study designed to determine the safety and efficacy of IFN-g 1b
administered by subcutaneous injection; compared to placebo in patients with IPF who are
unresponsive to steroids. 330 patients have been enrolled and were assigned to either a IFN-g
1b group or a placebo group.